EGFR mutations were detected in 4/10 of patients with AIS (22.2%), in 12/18 of patients with MIA (59.5%), and in 363/2419 of patients with ADC (15.0%; Figure 2 and Figure 3). This evidence concerns the gene EGFR and androgen insensitivity syndrome.